{ "model": { "rank": 3632, "code": "thing-q160105", "model_id": "vr.tr.cervix-uterine-cancer", "name": "cervix uterine cancer", "purpose": "Let an agent explain cervical cancer and its prevention in general terms from oncology and public health guidelines, describe screening, symptoms, diagnosis and treatment, and route personal questions to clinicians.", "family": "Thing Registry", "category": "Information and virtual systems", "status": "research-draft", "kind": "thing", "plane": "INF", "domain": "INF.KNW", "industry": "", "version": "", "url": "/models/thing/q160105/", "tier": 2, "score": 83, "payload": { "layer": "wikidata", "aliases": [ "AIDS-related cervical cancer", "cervix carcinoma", "cervical neuroendocrine carcinoma", "cervical adenomyoma", "cervix melanoma", "cervical carcinosarcoma", "cervical alveolar soft part sarcoma", "cervix endometrial stromal tumor", "metastatic malignant neoplasm to the cervix", "Glassy cell carcinoma of the cervix", "sarcoma of cervix uteri", "malignant neoplasm of endocervix", "Villoglandular adenocarcinoma of the cervix" ], "aliasCount": 13, "merged": 13, "knownIn": 83, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q160105", "url": "https://www.wikidata.org/wiki/Q160105", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-13T04:34:01Z", "providers": [ "Claude" ], "breadth": "written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify", "pass": 2, "wave": 3, "engine": "claude" }, "metaModel": { "id": "THING-Q160105", "registryId": "vr.tr.cervix-uterine-cancer", "name": "cervix uterine cancer", "version": "0.2.0-wave.3", "entryKind": "thing", "family": "Thing Registry", "domain": [ "INF.KNW" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q160105/", "model": { "registry_id": "vr.tr.cervix-uterine-cancer", "name": "cervix uterine cancer", "purpose": "Let an agent explain cervical cancer and its prevention in general terms from oncology and public health guidelines, describe screening, symptoms, diagnosis and treatment, and route personal questions to clinicians.", "definition": "A cancer arising from the cervix, the lower part of the uterus, almost always caused by persistent infection with high-risk human papillomavirus types, mostly squamous cell carcinoma and adenocarcinoma with rare types such as neuroendocrine carcinoma, carcinosarcoma and melanoma, preventable by HPV vaccination and detectable early by screening with cytology and HPV testing, and more frequent in women with HIV as an AIDS-defining cancer; cervical cancer remains a leading cause of cancer death in low-income countries and is targeted for elimination by WHO.", "what_it_is_for": "Not applicable; a cancer.", "affordances": [ "explain the cancer and causes", "relay prevention and screening", "relay treatment and outcomes", "route personal questions" ], "distinguishing_features": [ "HPV causation", "Vaccine preventable", "Screen detectable", "Global inequity" ], "appearance": "Not a visible object; abnormal cells or a tumour of the cervix.", "visual_identification": [ "Cancer of the uterine cervix", "Squamous cell carcinoma, adenocarcinoma, neuroendocrine carcinoma, carcinosarcoma, melanoma; AIDS-related cervical cancer", "Cervical intraepithelial neoplasia is precancerous; endometrial cancer arises in the uterine body" ], "physical_properties": [ { "quantity": "new cases worldwide", "typical_range": "about 660000", "unit": "per year", "note": "GLOBOCAN 2022" }, { "quantity": "deaths worldwide", "typical_range": "about 350000", "unit": "per year", "note": "" }, { "quantity": "HPV-attributable share", "typical_range": "over 95", "unit": "percent", "note": "" } ], "families_and_kinds": [ "squamous cell carcinoma of the cervix", "cervical adenocarcinoma", "rare types such as neuroendocrine carcinoma, carcinosarcoma and melanoma", "AIDS-related cervical cancer", "precancerous cervical intraepithelial neoplasia", "benign lesions such as cervical adenomyoma as distinct entities" ], "related_models": [ { "relation": "is a kind of", "target": "uterine cervix neoplasm", "why": "in registry terms" }, { "relation": "is a kind of", "target": "uterine cancer", "why": "in registry terms" }, { "relation": "is caused by", "target": "human papillomavirus", "why": "high-risk types" }, { "relation": "is prevented by", "target": "HPV vaccine", "why": "and screening" } ], "identifiers": [ { "scheme": "ICD-11", "value_or_pattern": "2C77", "note": "malignant neoplasms of cervix uteri" }, { "scheme": "MeSH", "value_or_pattern": "D002583", "note": "uterine cervical neoplasms" } ], "standards_and_regulation": [ "WHO cervical cancer elimination strategy", "National screening programmes", "HPV vaccination schedules", "ESGO, NCCN and other oncology guidelines" ], "failure_modes_and_hazards": [ "Missed screening", "Agents giving personal medical advice", "Vaccine misinformation", "Inequitable access to screening and treatment" ], "in_scope": [], "out_of_scope": [], "characteristics": [] }, "sources": [], "structure": { "bundles": [ { "id": "help", "name": "Help", "description": "Getting help first.", "rationale": "Safety.", "layers": [ { "id": "signs", "name": "Signs", "description": "Warning signs.", "findings": [ { "id": "signs-finding", "name": "Signs", "description": "Signs.", "questions": [ { "text": "What symptoms, such as abnormal bleeding or discharge, need prompt assessment?", "kind": "action" }, { "text": "Is the user describing such symptoms, which need a clinician promptly?", "kind": "boundary" } ] } ] }, { "id": "screening", "name": "Screening", "description": "Screening.", "findings": [ { "id": "screening-finding", "name": "Screening", "description": "Screening.", "questions": [ { "text": "How do cytology and HPV screening programmes work, and who is invited?", "kind": "provenance" }, { "text": "Is the user asking about their own results, which need their clinician?", "kind": "boundary" } ] } ] } ] }, { "id": "understand", "name": "Understand", "description": "The cancer.", "rationale": "Clinical.", "layers": [ { "id": "causes", "name": "Causes", "description": "Causes and types.", "findings": [ { "id": "causes-finding", "name": "Causes", "description": "Causes.", "questions": [ { "text": "How does HPV cause cervical cancer, and what types including rare forms exist?", "kind": "definition" }, { "text": "Is the question about cervical cancer, precancer or endometrial cancer?", "kind": "boundary" } ] } ] }, { "id": "risk", "name": "Risk", "description": "Risk factors.", "findings": [ { "id": "risk-finding", "name": "Risk", "description": "Risk.", "questions": [ { "text": "What factors such as HIV, smoking and lack of screening increase risk?", "kind": "provenance" }, { "text": "Which entry fits the specific risk factor?", "kind": "action" } ] } ] } ] }, { "id": "treat", "name": "Treat", "description": "Prevention and treatment.", "rationale": "Clinical.", "layers": [ { "id": "prevention", "name": "Prevention", "description": "Vaccination.", "findings": [ { "id": "prevention-finding", "name": "Prevention", "description": "Prevention.", "questions": [ { "text": "How does HPV vaccination prevent cervical cancer, and what does WHO recommend?", "kind": "provenance" }, { "text": "Which references are standard?", "kind": "provenance" } ] } ] }, { "id": "treatment", "name": "Treatment", "description": "Treatment.", "findings": [ { "id": "treatment-finding", "name": "Treatment", "description": "Treatment.", "questions": [ { "text": "What treatments do guidelines recommend by stage, from surgery to chemoradiation and immunotherapy, in general terms?", "kind": "provenance" }, { "text": "Which sources are cited?", "kind": "provenance" } ] } ] } ] }, { "id": "context", "name": "Context", "description": "Global health and history.", "rationale": "Context.", "layers": [ { "id": "global", "name": "Global", "description": "Global elimination.", "findings": [ { "id": "global-finding", "name": "Global", "description": "Global.", "questions": [ { "text": "What is the WHO elimination strategy, and how does burden vary worldwide?", "kind": "provenance" }, { "text": "Which entry fits global cancer control?", "kind": "action" } ] } ] }, { "id": "history", "name": "History", "description": "History.", "findings": [ { "id": "history-finding", "name": "History", "description": "History.", "questions": [ { "text": "How did the Pap test and the discovery of HPV causation change cervical cancer?", "kind": "provenance" }, { "text": "Which entry fits the history of cancer screening?", "kind": "action" } ] } ] } ] } ] }, "openQuestions": [ "Should HPV vaccine and cervical screening be separate primary entries?", "How should WHO and oncology guidelines be linked?", "The registry entry has merged aliases naming rare types and a benign lesion; should they be split off?" ], "statistics": { "bundles": 4, "layers": 8, "findings": 8, "questions": 16 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "disease or condition", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a cervix uterine cancer, record what state it is in, and decide what may be done with it.", "whatItIs": "Let an agent explain cervical cancer and its prevention in general terms from oncology and public health guidelines, describe screening, symptoms, diagnosis and treatment, and route personal questions to clinicians.", "characteristics": { "substance": "information", "origin": "conceptual", "agency": "inert" }, "whatYouCanDoWithIt": [ "read and interpreted" ], "distinguishingFeatures": [ "Names folded into this entry, which a task may need to split apart again: AIDS-related cervical cancer, cervix carcinoma, cervical neuroendocrine carcinoma, cervical adenomyoma, cervix melanoma, cervical carcinosarcoma, cervical alveolar soft part sarcoma, cervix endometrial stromal tumor, metastatic malignant neoplasm to the cervix, Glassy cell carcinoma of the cervix, sarcoma of cervix uteri, malignant neoplasm of endocervix.", "13 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.", "Described in 83 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a cervix uterine cancer, and on what evidence are they told apart?" ], "whatItIsMadeOf": "content that has to be carried by something else", "physicalCharacter": [ "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "read it and act on what it says" ], "howItIsRecognised": [ "Recognised by criteria applied to signs and findings, not by appearance. Two conditions can look identical and be distinguished only by test." ], "relatedModels": [ { "relation": "covers", "note": "Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.", "targets": [ "AIDS-related cervical cancer", "cervix carcinoma", "cervical neuroendocrine carcinoma", "cervical adenomyoma", "cervix melanoma", "cervical carcinosarcoma", "cervical alveolar soft part sarcoma", "cervix endometrial stromal tumor", "metastatic malignant neoplasm to the cervix", "Glassy cell carcinoma of the cervix", "sarcoma of cervix uteri", "malignant neoplasm of endocervix" ] } ], "standing": "Described in 83 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 13 finer distinctions are held inside this entry as names rather than as separate models.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one cervix uterine cancer from another, and a cervix uterine cancer from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a cervix uterine cancer, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a cervix uterine cancer, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a cervix uterine cancer is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a cervix uterine cancer, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a cervix uterine cancer, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a cervix uterine cancer is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a cervix uterine cancer sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a cervix uterine cancer, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a cervix uterine cancer, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a cervix uterine cancer is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a cervix uterine cancer from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a cervix uterine cancer, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a cervix uterine cancer, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a cervix uterine cancer is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a cervix uterine cancer passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a cervix uterine cancer between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a cervix uterine cancer, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a cervix uterine cancer, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a cervix uterine cancer is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a cervix uterine cancer, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a cervix uterine cancer is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a cervix uterine cancer, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a cervix uterine cancer, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a cervix uterine cancer is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "content-and-access", "name": "Content, encoding and access", "description": "What a cervix uterine cancer says, how it is encoded and who may read it.", "rationale": "An informational thing carries content that can be copied, versioned and withheld, none of which its physical carrier explains.", "layers": [ { "id": "content-and-encoding", "name": "Content and encoding", "description": "The content itself, its format and its language.", "findings": [ { "id": "content-and-format", "name": "Content, format and language", "description": "What a cervix uterine cancer contains and in what form it is held.", "questions": [ { "id": "content-and-format-q01", "text": "What identifies and describes the content of a cervix uterine cancer, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "content-and-format-q02", "text": "Who or what asserted this about the content of a cervix uterine cancer, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "content-and-format-q03", "text": "What may an agent decide or do once the content of a cervix uterine cancer is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "access-and-rights", "name": "Access, rights and retention", "description": "Who may read, copy or change it, and for how long it is kept.", "findings": [ { "id": "access-rules", "name": "Access rules and retention", "description": "The permissions attached to a cervix uterine cancer and the period it survives.", "questions": [ { "id": "access-rules-q01", "text": "What identifies and describes access to a cervix uterine cancer, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "access-rules-q02", "text": "Who or what asserted this about access to a cervix uterine cancer, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "access-rules-q03", "text": "What may an agent decide or do once access to a cervix uterine cancer is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "diagnosis-and-criteria", "name": "Diagnosis, criteria and coding", "description": "What makes a case of cervix uterine cancer a case, and under which revision.", "rationale": "Criteria change between revisions, so a diagnosis without its coding revision cannot be compared with a later one.", "layers": [ { "id": "criteria", "name": "Diagnostic criteria", "description": "The criteria in force and who issues them.", "findings": [ { "id": "criteria-record", "name": "Criteria, issuer and revision", "description": "What must be true for a diagnosis, according to whom.", "questions": [ { "id": "criteria-record-q01", "text": "What criteria define cervix uterine cancer, issued by which body, in which revision?", "kind": "definition" }, { "id": "criteria-record-q02", "text": "What changed between revisions that would reclassify existing cases?", "kind": "boundary" } ] } ] }, { "id": "coding", "name": "Coding and terminology", "description": "The codes used to record it and their mapping.", "findings": [ { "id": "coding-record", "name": "Codes and mappings", "description": "Which classification codes apply and how they map.", "questions": [ { "id": "coding-record-q01", "text": "Which classification and terminology codes cover cervix uterine cancer, and how do they map to each other?", "kind": "definition" }, { "id": "coding-record-q02", "text": "What is lost when a case is mapped from one scheme to another?", "kind": "boundary" } ] } ] } ] }, { "id": "course-and-population", "name": "Course, population and care", "description": "How cervix uterine cancer develops, whom it affects, and what is done about it.", "rationale": "The condition, the diagnosis and the episode of care are three different things, and an agent must not merge them.", "layers": [ { "id": "course", "name": "Course and stages", "description": "Onset, progression, remission and outcome.", "findings": [ { "id": "course-record", "name": "Stages and transitions", "description": "The stages recorded and what moves a case between them.", "questions": [ { "id": "course-record-q01", "text": "What course does cervix uterine cancer typically take, and what marks each stage?", "kind": "definition" }, { "id": "course-record-q02", "text": "What separates the condition itself from an episode of care for it?", "kind": "boundary" } ] } ] }, { "id": "population", "name": "Affected populations", "description": "Who is affected, how often, and on what evidence.", "findings": [ { "id": "epidemiology", "name": "Prevalence and its basis", "description": "Rates with their population, period and source.", "questions": [ { "id": "epidemiology-q01", "text": "What prevalence or incidence is reported for cervix uterine cancer, in which population and period?", "kind": "measurement" }, { "id": "epidemiology-q02", "text": "What may an agent not conclude about an individual from a population rate?", "kind": "action" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a cervix uterine cancer came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a cervix uterine cancer and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a cervix uterine cancer, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a cervix uterine cancer, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a cervix uterine cancer is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a cervix uterine cancer is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a cervix uterine cancer, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a cervix uterine cancer, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a cervix uterine cancer is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 6, "layers": 12, "findings": 14, "questions": 38 } } } }